Navigation Links
China Medical Technologies Reports Second Quarter Financial Results
Date:11/20/2007

her things, the quotations from management in this press release, the Company's strategic operational plans, as well as outlook for FY2007, contain forward-looking statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in the Company's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

China Medical Technologies, Inc.

Unaudited Condensed Consolidated Balance Sheets

As of

June 30,

March 31, 2007 September 30,

2007 Restated(1) 2007

RMB RMB RMB US$

(in thousands)

Assets

Current assets

Cash and cash equivalents 1,173,640 1,145,271 994,214 132,689

Trade accounts receivable 201,778 215,335 227,317 30,338

Prepayments and other

receivables 41,484 45,568 28,175 3,761

Inventories 27,991 31,902 34,423 4,594

Total current assets 1,444,893 1,438,076 1,284,129 171,382

Property, plant and equipment,

net 135,792 147,075 151,333 20,197

Intangible assets, net 1,565,362 1,523,530 1,480,877 197,640

Lease prepayments, net 7,619 7,573 7,525 1,004

Prepayment and other

<
'/>"/>
SOURCE China Medical Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... , - ... the Ability of,Cardiopoietic Cells to Restore Cardiac Function ... leading Belgian biotechnology company specialising,in cell-based therapies for ... has completed, two months ahead of schedule,enrolment in ... trial of C-Cure, a,unique stem cell therapy for ...
(Date:12/14/2009)... and THOUSAND OAKS, Calif., Dec. 14 ... Amgen Inc.(Nasdaq: AMGN ) today announced that ... worldwide rights to Array,s small-molecule glucokinase activator program, ... 1 clinical trial in patients with Type 2 ... the agreement, Array will receive an upfront payment ...
(Date:12/14/2009)... Dyadic International, Inc. (Pink Sheets: DYAI) ... collaboration with The Scripps Research Institute ("Scripps") by ... the genome of Dyadic,s patented and proprietary C1 ... of the successful relationship between the two organizations ... Scripps to annotate the C1 genome for the ...
(Date:12/14/2009)... N.J., Dec. 14 The third edition ... , published by the Infusion ... treatment for anthracycline extravasation.(1) Anthracyclines are a ... and epirubicin that have been used in the ... early 1970s.(2) ,, According to the ...
Breaking Biology Technology:Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5
... (Nasdaq: KOOL ), a leading supplier of innovative ... for treatment of disease,and injury, today reported results for ... Revenues for the quarter ended December 31, 2007, ... for the second quarter of,fiscal 2007 and $3.6 million ...
... YORK, Feb. 6 Immtech Pharmaceuticals,Inc. (Amex: IMM ... February,11, 2008, at 4.30 PM (ET) to discuss its ... to present an update on the Company,s,scientific and clinical ... to join the call by dialing (888) 338-8374 and ...
... Risk of Heart ... Disease and Diabetes, BIRMINGHAM, ... the largest private,insurers in Arizona as well as Medicare, Medicaid and ... Auto Profile),Test, the most comprehensive cholesterol test available. That means almost,90 ...
Other Biology Technology:ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year 2ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year 3ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year 4ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year 5ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year 6ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year 7ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year 8Immtech Investor Conference Call Scheduled for February 11, 2008 2VAP Cholesterol Test From Atherotech Covers 90 Percent of Arizona Insured 2
(Date:12/14/2009)... Society (BMES) have founded a new journal Cardiovascular ... CVET is a forum for research on all ... first issue of the new quarterly journal will appear ... at Springer, Annals of Biomedical Engineering and ... Engineering and Technology will present a wide spectrum ...
(Date:12/14/2009)... Nations Framework Convention on Climate Change taking place ... ,Bend the Trend, event on Sunday evening to ... the screening of the new ,Environmental Atlas of ... joint project of the European Environment Agency (EEA), ... a series of short films showing the significance ...
(Date:12/13/2009)... Conn.A team led by Yale University researchers has ... blood for the first time. Their findings, which ... of Nature Nanotechnology , could dramatically simplify ... and other diseases. , The teamled ... Engineering & Applied Science, and Tarek Fahmy, an ...
Breaking Biology News(10 mins):Biomedical Engineering Society's new journal to be published by Springer 2'Environmental Atlas of Europe' unveiled at COP15 2Scientists use nanosensors for first time to measure cancer biomarkers in blood 2The worlds most common operation 60981 1Antarctica glacier retreat creates new carbon dioxide store 10666 1Antarctica glacier retreat creates new carbon dioxide store 10666 2Charles Darwin and modern biology 10661 1
... to the largest body of ice on Earth. Prior to ... exist beneath the Antarctic ice sheets, which can be more ... to be too extreme. However, Brent Christner, assistant professor of ... time in one of the worlds most hostile environments conducting ...
... forest cover in El Salvador in the September issue ... land policy changes, and monies sent to family members ... The study, by Susanna B. Hecht and Sassan S. ... to document substantial increases in the area of El ...
... at Chicago researchers have identified new sites on ... be delivered to treat infections. , "The primary ... caused by the pathogens which became resistant to ... of UIC,s Center for Pharmaceutical Biotechnology and lead ...
Other Biology News:LSU professor looks for life in and under antarctic ice 2LSU professor looks for life in and under antarctic ice 3Population movements and money remittances spur forest regrowth 2UIC researchers find promising new targets for antibiotics 2
... The CopyControl™ vector can be induced ... These vectors provide the stability of single-copy ... cosmids or other cloning vectors. The kits ... (ligation reagents, insert size screening system) necessary ...
... 3T3 cells were cultured in DMEM with 4 ... of growth. In order to keep the ... in acetone-methanol. The cells are arrayed on ... each wells surface specifically treated to enhance cellular ...
... vector can be induced prior to DNA ... the stability of single-copy BACs with the ... cloning vectors. The kits provide the linearized ... size screening system) necessary to create a ...
...
Biology Products: